Megan Robblee

Megan Robblee is a Senior Scientist in Inflammation Drug Discovery with a PhD in Biomedical Sciences. They have over 10 years of experience in metabolic disease research, culminating in six publications. Megan possesses in vivo expertise in assessing metabolic pathways using rodent models and has applied various techniques in genetic, molecular, and cell biology to identify therapeutic targets. They held positions as a Postdoctoral Scholar at the University of California, San Francisco, and as a Research Assistant at The Rockefeller University, where they contributed to significant advancements in understanding metabolic inflammation and atherosclerosis. Currently, Megan continues to expand their expertise in the field while working at Amgen.